|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. R.J. Reynolds Tobacco Company Michael Borgerding J.Donald deBethizy David Doolittle David Iauco Arnold T.Mosberg Seth Moskowitz John H.Robinson Robert L.Suber James E.Swauger Star Scientific, Inc. Scott D.Ballin Jerome H.Jaffe Paul L.Perito GlaxoWellcome Pharmacutical Brenda Jamerson Pharmacia Corporation Mikael Franzon Vibeke Kronborg Smith Kline Beecham Individuals Gregory Dalack, VA Ann Arbor Healthcare System Karl Fagerstrom, Fagerstrom Consulting Nigel Gray, European Institute of Oncology Jack Henningfield, Pinney Associates Thomas Houston, American Medical Association John Hughes, University of Vermont Anne Kirchner, Food and Drug Administration Robert Nilsson, National Chemicals Inspectorate, Sweden Brad Radu, University of Alabama Elsy-Britt Schildt, University Hospital, Sweden Saul Shiffman, University of Pittsburgh and Pinney Associates John Slade, University of Medicine and Dentistry at New Jersey School of Public Health Steven Stellman, American Health Foundation David Sweanor, Smoking and Health Action Foundation, Canada Puzant Torigian Dennis Ole Wik Judy Wilkenfeld, Campaign for Tobacco Free Kids Richard Windsor, University of Alabama
|
|
|||||||||||||||
